Indian J Surg Oncol. 2022 Sep;13(3):481-487. doi: 10.1007/s13193-021-01487-2. Epub 2022 Jan 19.
PMID:36187512
Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?
Chu L, Liu S, Guo T, Zou L, Li B, Ni J, Yang X, Chu X, Liang F, Li Y, Sun Y, Li Q, Yin F, Li G, Zhu Z.
Front Oncol. 2022 Feb 25;12:814238. doi: 10.3389/fonc.2022.814238. eCollection 2022.
PMID:35280825
Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness.
Tang W, Qiu JG, Deng X, Liu SS, Cheng L, Liu JR, Du CY.
PLoS One. 2021 Mar 11;16(3):e0248534. doi: 10.1371/journal.pone.0248534. eCollection 2021.
PMID:33705481
Risk Factors for Negative Emotions in Patients Undergoing Radical Resection of Hilar Cholangiocarcinoma and Their Influence on Prognosis.
Yin R, Xu S, Zhu J, Zhu H, He C.
Int J Gen Med. 2023 Dec 11;16:5841-5853. doi: 10.2147/IJGM.S440469. eCollection 2023.
PMID:38106978
Total Laparoscopic Radical Resection of S1 + S4 for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma (With Video).
Huang J, Li JW, Xu D.
Ann Surg Oncol. 2024 Sep;31(9):5631-5635. doi: 10.1245/s10434-024-15531-2. Epub 2024 Jun 4.